Skip to main content
. 2018 Oct 3;4:44. doi: 10.1038/s41420-018-0108-8

Fig. 7. YL064 inhibits myeloma tumor growth in vivo.

Fig. 7

a, b Mice bearing MM1.S MM tumors were treated with either YL064 (30 mg/kg; IP) or vehicle daily for 9 days. Tumor volume was measured every 2 days (a). Body weight were measured every 2 days (b). c The hematoxylin–eosin staining analysis of tumors. The indicated proteins were examined by immunohistochemistry (IHC) in tumor tissues (c). *p < 0.05, vehicle vs YL064-treated group. Scale bar = 50 μm